NO20074536L - Anvendelse av jern (III)-komplekssammensetninger - Google Patents

Anvendelse av jern (III)-komplekssammensetninger

Info

Publication number
NO20074536L
NO20074536L NO20074536A NO20074536A NO20074536L NO 20074536 L NO20074536 L NO 20074536L NO 20074536 A NO20074536 A NO 20074536A NO 20074536 A NO20074536 A NO 20074536A NO 20074536 L NO20074536 L NO 20074536L
Authority
NO
Norway
Prior art keywords
iron
iii
complex compositions
complex
carbohydrates
Prior art date
Application number
NO20074536A
Other languages
English (en)
Inventor
Peter Geisser
Jessica Tanner-Baumgartner
Ranjeet Chandra
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of NO20074536L publication Critical patent/NO20074536L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse angår nye terapeutiske anvendelser av jem(III) kompleksforbindelser med karbohydrater eller derivater derav for fremstilling av et medikament som fremmer immunforsvar og/eller hjernekraft.
NO20074536A 2005-02-09 2007-09-07 Anvendelse av jern (III)-komplekssammensetninger NO20074536L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100907 2005-02-09
PCT/EP2006/050276 WO2006084782A1 (de) 2005-02-09 2006-01-18 Verwendung von eisen(iii)-komplexverbindungen

Publications (1)

Publication Number Publication Date
NO20074536L true NO20074536L (no) 2007-11-05

Family

ID=34938674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074536A NO20074536L (no) 2005-02-09 2007-09-07 Anvendelse av jern (III)-komplekssammensetninger

Country Status (26)

Country Link
US (2) US8722101B2 (no)
EP (1) EP1848446B1 (no)
JP (1) JP5060312B2 (no)
KR (1) KR20070107106A (no)
CN (1) CN101155593A (no)
AT (1) ATE445406T1 (no)
AU (1) AU2006212322B2 (no)
BR (1) BRPI0606974A2 (no)
CA (1) CA2597154C (no)
CR (1) CR9300A (no)
CY (1) CY1109685T1 (no)
DE (1) DE502006005100D1 (no)
DK (1) DK1848446T3 (no)
ES (1) ES2333814T3 (no)
HR (1) HRP20100027T1 (no)
IL (1) IL185020A (no)
MX (1) MX2007009588A (no)
NO (1) NO20074536L (no)
PL (1) PL1848446T3 (no)
PT (1) PT1848446E (no)
RU (1) RU2359680C2 (no)
SI (1) SI1848446T1 (no)
TN (1) TNSN07307A1 (no)
UA (1) UA88347C2 (no)
WO (1) WO2006084782A1 (no)
ZA (1) ZA200707716B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
EP2626074A1 (en) 2006-01-06 2013-08-14 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
UA103373C2 (ru) * 2009-03-25 2013-10-10 Фармакосмос Голдинг А/С Стабильное соединение феррума олигосахарида
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US11395502B2 (en) * 2012-10-18 2022-07-26 Patrick Monsivais Formulation for iron supplements
EP2978427B1 (de) * 2013-03-28 2018-08-08 Vifor (International) AG Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
KR20150078375A (ko) * 2013-12-30 2015-07-08 한화케미칼 주식회사 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물
FR3075001B1 (fr) * 2017-12-14 2021-09-10 Tereos Starch & Sweeteners Belgium Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
CN114288320A (zh) * 2021-12-29 2022-04-08 珠海天翼医药技术开发有限公司 一种猪用口服补铁剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
DE4421159C1 (de) 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
EP1363951B1 (en) * 2000-12-07 2006-10-25 AD "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrzivanje I Razvoj Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
EP1377594A4 (en) 2001-04-10 2004-06-30 Danisco Usa Inc POLYMERIZATION OF MONO AND DISACCHARIDES WITH MONOCARBOXYLIC ACIDS AND LACTONS
NZ535761A (en) 2002-04-09 2007-09-28 Pharmacosmos Holding As Iron dextrin compounds for the treatment of iron deficiency anaemia
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
US20140187514A1 (en) 2014-07-03
KR20070107106A (ko) 2007-11-06
DK1848446T3 (da) 2010-02-15
AU2006212322B2 (en) 2012-01-19
PT1848446E (pt) 2009-12-21
JP5060312B2 (ja) 2012-10-31
SI1848446T1 (sl) 2010-01-29
MX2007009588A (es) 2007-09-12
US8722101B2 (en) 2014-05-13
CA2597154A1 (en) 2006-08-17
CR9300A (es) 2007-12-07
PL1848446T3 (pl) 2010-03-31
CY1109685T1 (el) 2014-08-13
WO2006084782A1 (de) 2006-08-17
EP1848446B1 (de) 2009-10-14
EP1848446A1 (de) 2007-10-31
BRPI0606974A2 (pt) 2009-07-28
AU2006212322A1 (en) 2006-08-17
JP2008530049A (ja) 2008-08-07
IL185020A0 (en) 2007-12-03
UA88347C2 (ru) 2009-10-12
ATE445406T1 (de) 2009-10-15
CN101155593A (zh) 2008-04-02
DE502006005100D1 (de) 2009-11-26
RU2359680C2 (ru) 2009-06-27
US20080214496A1 (en) 2008-09-04
ZA200707716B (en) 2008-06-25
RU2007133509A (ru) 2009-03-20
HRP20100027T1 (hr) 2010-02-28
ES2333814T3 (es) 2010-03-01
TNSN07307A1 (en) 2008-12-31
CA2597154C (en) 2011-03-15
IL185020A (en) 2013-10-31

Similar Documents

Publication Publication Date Title
NO20074536L (no) Anvendelse av jern (III)-komplekssammensetninger
MY146969A (en) Dpp iv inhibitor formulations
WO2006124861A3 (en) Benzofuran compounds
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
EA201170703A1 (ru) Производные адамантилбензамида
MX2010001849A (es) Depsipeptidos ciclicos.
TW200942524A (en) Novel aminomethyl benzene derivatives
JO2721B1 (en) Derivatives of artemisia plant and its preparations and therapeutic applications
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
MX342947B (es) Tratamiento de diabetes tipo 2.
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
MX2012007896A (es) Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica.
TW200726763A (en) Novel compound
EA201000392A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
EA201000432A1 (ru) Фунгицидные смеси тритиконазола и дифеноконазола
WO2009151495A3 (en) Oxazole compounds, compositions and methods of use
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2009005182A (es) Derivados de 2-hidroxi-1,3-diamino-propano.
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
EA200870565A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application